Related references
Note: Only part of the references are listed.Prediction of response to interferon therapy in multiple sclerosis
F. Sellebjerg et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
New management algorithms in multiple sclerosis
Per Soelberg Sorensen
CURRENT OPINION IN NEUROLOGY (2014)
An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity
Linda Ottoboni et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Organellar Na+/H+ Exchangers: Novel Players in Organelle pH Regulation and Their Emerging Functions
Ryuichi Ohgaki et al.
BIOCHEMISTRY (2011)
Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults
Jennifer E. Huffman et al.
HUMAN MOLECULAR GENETICS (2011)
Multiple sclerosis pharmacogenomics Maximizing efficacy of therapy
Derek J. Pappas et al.
NEUROLOGY (2010)
Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple Sclerosis
Manuel Comabella et al.
ARCHIVES OF NEUROLOGY (2009)
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
Richard A. Rudick et al.
LANCET NEUROLOGY (2009)
Genome-wide pharmacogenomic analysis of the response to interferon β therapy in multiple sclerosis
Esther Byun et al.
ARCHIVES OF NEUROLOGY (2008)
Share Paper
